Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06211764 SunRISe-5 — A Study of TAR-200 Versus Intravesical Chemotherapy in Part… |
TAR-200 | Cancer | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Argentina, Belgium, Brazil, China, Fra… | 2024-04-09 → 2031-04-14 | Ouvrir |
| NCT07525206 AndroMETa-CRC — A Study to Access Intravenous (IV) Telisotuzumab Adizut… |
Telisotuzumab Adizutecan | Cancer | Phase 3 | RECRUITING | En attente / non publié | AbbVie | United States, Belgium, China, Germany, Greece, Japan… | 2026-05-22 → 2030-03 | Ouvrir |
| NCT06801236 Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-R… |
ACE-232 tablets | Cancer | Phase 1 | RECRUITING | En attente / non publié | Acerand Therapeutics (Hong Kong) … | United States, China · Beijing Gobroard Hospital, Bei… | 2025-05-12 → 2028-12-31 | Ouvrir |
| NCT07670312 Evaluation of XYA02 in Patients With Advanced Solid Tumors |
XYA02 | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | XYone Therapeutics, Inc | Australia · Chris O'Brien Life House, Sydney, Austral… | 2026-09-17 → 2030-09-15 | Ouvrir |
| NCT07164443 KLK2-comPAS — A Study of Pasritamig With or Without JNJ-87189401 Versus… |
Pasritamig | Cancer | Phase 3 | RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Australia, Belgium, Brazil, Canada, Ch… | 2025-09-02 → 2028-08-18 | Ouvrir |
| NCT06349408 IBI3001 in Participants With Unresectable, Locally Advanced or Metastat… |
IBI3001 | Cancer | Phase 1 | RECRUITING | En attente / non publié | Fortvita Biologics (USA)Inc. | United States, Australia, China · Anyang Cancer Hospi… | 2025-01-10 → 2027-12-31 | Ouvrir |
| NCT06091865 OLYMPIA-3 — A Study to Compare How Well Odronextamab Combined With Chem… |
Odronextamab | Cancer | Phase 3 | RECRUITING | En attente / non publié | Regeneron Pharmaceuticals | United States, Australia, Austria, Belgium, Brazil, C… | 2023-12-13 → 2029-09-12 | Ouvrir |
| NCT07841002 CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory… |
SL1CC Injection | Cancer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Liping Dou | China · Chinese PLA General Hospital, Beijing, Beijin… | 2026-09-30 → 2030-09-30 | Ouvrir |
| NCT07377006 Decision Support Tool to Enhance Germline Genetic Testing for Patients … |
Biospecimen Collection | Cancer | Non applicable | RECRUITING | En attente / non publié | City of Hope Medical Center | United States · M D Anderson Cancer Center, Houston, … | 2026-02-02 → 2030-12-31 | Ouvrir |
| NCT07704970 QLESP Block for Pain Control in Robotic Partial Nephrectomy |
ropivacaine (local infiltration) | Cancer | Non applicable | RECRUITING | En attente / non publié | Huazhong University of Science an… | China · Union Hospital, Tongji Medical College, Huazh… | 2026-09-22 → 2027-03-31 | Ouvrir |
| NCT04606381 PALOMA — A Study of Amivantamab Subcutaneous (SC) Administration for th… |
Ami-LC-MD | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Canada, South Korea, United Kingdom · … | 2020-11-10 → 2027-04-01 | Ouvrir |
| NCT05132075 KontRASt-02 — Study of JDQ443 in Comparison With Docetaxel in Participa… |
JDQ443 | Cancer | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Canada, China, F… | 2022-06-15 → 2026-10-03 | Ouvrir |
| NCT07842835 Registry of an Integrated Longitudinal Multimodal Biospecimen Biobank f… |
High-dose methotrexate-based ther… | Cancer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Xiaohui Ren | China · Deparment of neurosurgery, Beijing tiantan ho… | 2026-10-01 → 2031-07-31 | Ouvrir |
| NCT06667908 CONVERGE — A Study of JNJ-90301900 in Combination With Chemoradiation F… |
JNJ-90301900 | Cancer | Phase 2 | RECRUITING | En attente / non publié | Johnson & Johnson Enterprise Inno… | United States, Australia, Brazil, China, France, Hong… | 2024-12-06 → 2028-12-31 | Ouvrir |
| NCT07524530 Stem Cell Transplantation for Participants With Germline RUNX1 Associat… |
Cyclophosphamide | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | University of Washington | United States · National Institutes of Health Clinica… | 2026-09-30 → 2036-06-01 | Ouvrir |
| NCT02966665 : Vascular Function in Health and Disease |
BH4, L-NMMA, Vitamin C, Vitamin E… | Hypertension | Phase 1 | RECRUITING | En attente / non publié | D. Walter Wray | United States · University of Utah, Salt Lake City, U… | 2008-09 → 2030-08 | Ouvrir |
| NCT07842315 HTN-SCS — Spinal Cord Stimulation for Blood Pressure Control in Hyperte… |
Lower Thoracic Spinal Cord Stimul… | Hypertension | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of Calgary | Canada · Foothills Medical Center, Calgary, Canada | 2026-11-01 → 2030-11-01 | Ouvrir |
| NCT07361549 LIGHT 2 — Localized Injection of Lidocaine Via the Middle Meningeal Art… |
Lidocaine (drug) | Migraine | Phase 2 | RECRUITING | En attente / non publié | Daniel A Tonetti, MD | United States · Cooper University Health Care, Camden… | 2026-09-09 → 2031-07 | Ouvrir |
| NCT07837570 Comparison of the Effectiveness of Greater Occipital Nerve and Supratro… |
OnabotulinumtoxinA | Migraine | Phase 4 | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Non communiqué | 2026-10 → 2027-12 | Ouvrir |
| NCT07780136 Effectiveness of Greater Occipital Nerve and Supratrochlear Nerve Pulse… |
Ultrasound-guided pulsed radiofre… | Migraine | Phase 4 | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Non communiqué | 2026-10 → 2026-12 | Ouvrir |
| NCT07652034 EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Out… |
Middle Meningeal Artery embolizat… | Migraine | À vérifier | RECRUITING | En attente / non publié | The Affiliated Hospital Of Guizho… | United States · Cortex Neurovascular / TRA Union, Tac… | 2026-09-01 → 2028-06-01 | Ouvrir |
| NCT06473597 A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With … |
Rimegepant | Migraine | Phase 4 | RECRUITING | En attente / non publié | University of South Florida | United States · Maimonides Medical Center, Brooklyn, … | 2024-09-01 → 2028-12-31 | Ouvrir |
| NCT07835152 Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migrai… |
BR005-036C | Migraine | Phase 3 | NOT_YET_RECRUITING | En attente / non publié | Brise Pharmaceuticals Co., Ltd. | China · Affiliated Hospital of Jining Medical Univers… | 2026-09-30 → 2029-04-30 | Ouvrir |
| NCT06459648 PREDI-CGRP — Study for Prevent Chronification Migraine Through Predicti… |
Monoclonal antibody anti-CGRP | Migraine | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | Fundación de Investigación Bioméd… | Spain · Hospital Clinico Universitario de Valladolid,… | 2023-04-26 → 2026-12 | Ouvrir |
| NCT07497854 Rimegepant PMS — A Study to Learn About the Study Medicine NURTEC® ODT … |
Rimegepant sulfate | Migraine | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Pfizer | Non communiqué | 2027-03-01 → 2030-08-01 | Ouvrir |